AMGEVITA 100 MG/ML SOL INJ CT SER PREENC VD TRANS X 0,2 ML + AGU
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1024400150061 -
GGREM
544125010006607 -
Código de barras
7898609961234
O que a fonte publica
- Detentor do registro
- AMGEN BIOTECNOLOGIA DO BRASIL LTDA.
- Princípios ativos
- ADALIMUMABE
- Embalagem
- 100 MG/ML SOL INJ CT SER PREENC VD TRANS X 0,2 ML + AGU
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "AMGEVITA 100 MG/ML SOL INJ CT SER PREENC VD TRANS X 0,2 ML + AGU",
"holder": "AMGEN BIOTECNOLOGIA DO BRASIL LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7898609961234"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "544125010006607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "18.774.815/0001-93",
"priceRegime": "Regulado",
"productName": "AMGEVITA",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "100 MG/ML SOL INJ CT SER PREENC VD TRANS X 0,2 ML + AGU",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "725.93",
"icms-12": "824.92",
"icms-17": "874.61",
"icms-18": "885.28",
"icms-19": "896.21",
"icms-20": "907.41",
"icms-21": "918.90",
"icms-22": "930.68",
"icms-23": "942.77",
"icms-17.5": "879.91",
"icms-19.5": "901.78",
"icms-20.5": "913.12",
"icms-22.5": "936.68",
"icms-12-alc": "815.02",
"icms-17-alc": "864.12",
"icms-18-alc": "874.66",
"icms-19-alc": "885.46",
"icms-20-alc": "896.52",
"icms-21-alc": "907.87",
"icms-22-alc": "919.51",
"icms-23-alc": "931.45",
"withoutTaxes": "717.22",
"icms-17.5-alc": "869.36",
"icms-19.5-alc": "890.95",
"icms-20.5-alc": "902.16",
"icms-22.5-alc": "925.44"
},
"pisCofinsList": "Positiva",
"substanceText": "ADALIMUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "1000.62",
"icms-12": "1137.07",
"icms-17": "1205.56",
"icms-18": "1220.27",
"icms-19": "1235.33",
"icms-20": "1250.77",
"icms-21": "1266.61",
"icms-22": "1282.85",
"icms-23": "1299.51",
"icms-17.5": "1212.86",
"icms-19.5": "1243.01",
"icms-20.5": "1258.64",
"icms-22.5": "1291.12",
"icms-12-alc": "1126.72",
"icms-17-alc": "1194.60",
"icms-18-alc": "1209.17",
"icms-19-alc": "1224.10",
"icms-20-alc": "1239.39",
"icms-21-alc": "1255.08",
"icms-22-alc": "1271.17",
"icms-23-alc": "1287.67",
"withoutTaxes": "991.51",
"icms-17.5-alc": "1201.84",
"icms-19.5-alc": "1231.69",
"icms-20.5-alc": "1247.18",
"icms-22.5-alc": "1279.37"
},
"invalidBarcodes": [],
"activeSubstances": [
"ADALIMUMABE"
],
"therapeuticClass": "L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1024400150061",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L4B",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:544125010006607"